Internal Medicine, Hematology & Oncology · Rockville Centre, NY
NPI
1881751634
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
242 Merrick Rd, Suite 301
Rockville Centre, NY, 11570
Phone (516) 536-1455
Groups this clinician bills Medicare through
Medicare paid, 2024
$564K
58,727 services
Medicare patients, 2024
567
Average age 77
Drug cost, 2024
$2.3M
598 prescriptions
Company payments, 2025
$645
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Doron Weiner was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 36,423 times for 47 patients. In total Doron Weiner billed 58,727 services in 42 codes, and Medicare paid $564K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 36,423 | 47 | $2.33 | $85K |
| 85025 Blood Count | Office | 1,413 | 448 | $7.56 | $11K |
| 36415 Venipuncture Blood Collection | Office | 1,200 | 439 | $8.59 | $10K |
| 99214 Office E&M - Established | Office | 833 | 308 | $108.62 | $90K |
| 99213 Office E&M - Established | Office | 395 | 195 | $75.73 | $30K |
| 96372 Injection Administration | Office | 358 | 86 | $12.49 | $4,470 |
| 85610 Clinical Chemistry | Office | 112 | 18 | $4.20 | $470 |
| 99232 Hospital E&M - Subsequent | Facility | 72 | 46 | $67.89 | $4,888 |
| 99204 Office E&M - New | Office | 61 | 61 | $142.08 | $8,667 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 42 | 19 | $0.98 | $41.05 |
| 99222 Hospital E&M - Initial | Facility | 27 | 26 | $112.16 | $3,028 |
| 99195 Treatment - Miscellaneous | Office | 27 | 14 | $73.49 | $1,984 |
| 99215 Office E&M - Established | Office | 19 | 17 | $163.81 | $3,112 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $153.25 | $1,839 |
By year: 2022 $427K for 48,603 services; 2023 $454K for 53,219 services; 2024 $564K for 58,727 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,413 | 448 | $7.56 | $11K |
| 36415 Venipuncture Blood Collection | 1,200 | 439 | $8.59 | $10K |
| 85610 Clinical Chemistry | 112 | 18 | $4.20 | $470 |
Medicare prescription drug claims, 2024
In 2024, the drug Doron Weiner prescribed most often to Medicare patients was Hydroxyurea, with 112 prescriptions and refills. In total Doron Weiner wrote 598 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 112 | 306 | 32 | $2,844 |
| Tasigna Nilotinib Hcl | 39 | 39 | Under 11 | $736K |
| Warfarin Sodium Generic | 38 | 97 | Under 11 | $601 |
| Anastrozole Generic | 37 | 103 | 15 | $416 |
| Xarelto Rivaroxaban | 33 | 71 | Under 11 | $39K |
| Letrozole Generic | 26 | 64 | Under 11 | $440 |
| Eliquis Apixaban | 22 | 46 | Under 11 | $26K |
| Pomalyst Pomalidomide | 21 | 21 | Under 11 | $368K |
| Enoxaparin Sodium Generic | 21 | 28 | Under 11 | $6,344 |
| Imatinib Mesylate Generic | 16 | 20 | Under 11 | $2,265 |
| Dexamethasone Generic | 16 | 16 | Under 11 | $112 |
| Prednisone Generic | 15 | 39 | Under 11 | $171 |
| Ninlaro Ixazomib Citrate | 12 | 12 | Under 11 | $159K |
| Tamoxifen Citrate Generic | 11 | 32 | Under 11 | $293 |
Brand drugs: 187 claims; generic drugs: 411 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Doron Weiner $645 ($645 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novartis Pharmaceuticals Corporation with $194.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $194 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $129 |
| Menarini Silicon Biosystems, Inc. | 3 | $84.13 |
| Pfizer Inc. PFE | 3 | $78.43 |
| Abbvie Inc. ABBV | 2 | $53.93 |
| Incyte Corporation INCY | 1 | $26.76 |
| Merck Sharp & Dohme LLC MRK | 1 | $24.12 |
| Pharmacosmos Therapeutics Inc. | 1 | $22.49 |
| Daiichi Sankyo Inc. 4568.T | 1 | $18.11 |
| Genentech USA, Inc. ROG.SW | 1 | $14.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.